# Hypotonia and Neurofibromatosis Type 1 (NF1) Glioma

> **NCT02584413** · NA · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 29 (actual)

## Conditions studied

- Neurofibromatosis Type 1

## Interventions

- **DEVICE:** Magnetic resonance imaging
- **DRUG:** Gadolinium contrast

## Key facts

- **NCT ID:** NCT02584413
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-04-16
- **Primary completion:** 2019-02-07
- **Final completion:** 2019-02-07
- **Target enrollment:** 29 (ACTUAL)
- **Why stopped:** Low accrual rate
- **Last updated:** 2019-09-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02584413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02584413, "Hypotonia and Neurofibromatosis Type 1 (NF1) Glioma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02584413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*